Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2023 06:36 ET | Source: Transparency Market Research

Hernia Repair Devices Market Revenue to Cross USD 8.62 billion by 2031 – Exclusive Report by Transparency Market Research

Wilmington, Delaware, United States, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The hernia repair devices market was valued at US$ 5.5 billion in 2020. The hernia repair...
February 05, 2019 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference

FRAMINGHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will...
December 20, 2018 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019

FRAMINGHAM, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will...
December 17, 2018 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel

FRAMINGHAM, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
December 06, 2018 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event

FRAMINGHAM, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
December 04, 2018 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court

FRAMINGHAM, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
November 28, 2018 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe

FRAMINGHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices,...
October 17, 2017 02:30 ET | Source: P&S Market Research

Surgical Staplers Market to Reach $5.4 Billion by 2023: P&S Market Research

NEW YORK, Oct. 17, 2017 (GLOBE NEWSWIRE) -- According to new market research report titled “Surgical Staplers Market by Product (Manual Surgical Stapler, Powered Surgical Stapler), by Type...
March 12, 2014 13:02 ET | Source: Megadyne, Inc.

Megadyne(R) Adds ENDOPATH(R) Electrosurgery Probe Plus II to Electrosurgical Portfolio

DRAPER, UT--(Marketwired - Mar 12, 2014) - Megadyne Medical Products, a leading developer, manufacturer and supplier of electrosurgical products, today announced the expansion of its commercial...